Publications
![](https://www.crcl.fr/app/uploads/2021/02/scientific-reports_400x400.jpg)
Publié le 18/05/2020 - Sénescence cellulaire, cancer et vieillissement
Generation of a conditionaltransgenic mouse model expressing human Phospholipase A2 Receptor 1
Auteurs: Jaber S, Goehrig D, Bertolino P, Massemin A, Bihl F, Chabry J, Lambeau G, Vindrieux D, Bernard D
Journal: Scientific Reports
En savoir plusPublié le 14/05/2020 - Apoptose, cancer et développement
Blocking SHH/Patched Interaction Triggers Tumor Growth Inhibition through Patched-Induced Apoptosis.
Auteurs: Bissey PA, Mathot P, Guix C, Jasmin M, Goddard I, Costechareyre C, Gadot N, Delcros JG, Mali SM, Fasan R, Arrigo AP, Dante R, Ichim G, Mehlen P, Fombonne J.
Journal: Cancer Research
En savoir plus![](https://www.crcl.fr/app/uploads/2020/02/bioxriv.jpg)
Publié le 12/05/2020 - Inflammasome et cancer
NLRP3 controls ATM activation in response to DNA damage
Auteurs: Bodnar-Wachtel M.*, Huber A.L.*, Gorry J., Hacot S., Gérossier L., Guey B., Goutagny N., Bartosch B., Balot E., Ghiringhelli F., Py B., Couté Y., Ballesta A., Lantuejoul S., Hall J. and Petrilli V
Journal: bioRxiv
En savoir plusPublié le 05/05/2020 - Plateforme de gestion des échantillons biologiques
Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma
Auteurs: Andy Karabajakian, Thibaut Garrivier, Carole Crozes, Nicolas Gadot, Jean-Yves Blay, Frédéric Bérard, Philippe Céruse, Philippe Zrounba, Pierre Saintigny, Charles Mastier and Jérôme Fayette
Journal: Oncotarget
En savoir plusPublié le 01/05/2020 - Petites molécules pour cibles biologiques
Blocking SHH/patched interaction triggers tumor growth inhibition through patched-induced apoptosis
Auteurs: Bissey PA, Mathot P, Guix C, Jasmin M, Goddard I, Costechareyre C, Gadot N, Delcros JG, Mali SM, Fasan R, Arrigo AP, Dante R, Ichim G, Mehlen P, Fombonne J:
Journal: Cancer research
En savoir plusPublié le 24/04/2020 - Epigénétique, microenvironnement et cancer du foie
Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins
Auteurs: Kouton L, Boucraut J, Devaux J, ...., Merle P, ...., Attarian S, Delmont E
Journal: Clinical Neurophysiology
En savoir plus